IntraCellular Therapies (ITCI)
(Real Time Quote from BATS)
$68.64 USD
+0.09 (0.13%)
Updated Jun 7, 2024 10:48 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
Intra-Cellular Therapies Inc. [ITCI]
Reports for Purchase
Showing records 1 - 20 ( 24 total )
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for ITCI 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Intra-Cellular Therapies Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department